Tesamorelin itself is the active ingredient in FDA-approved prescription products for a limited indication

athletes subject to testing should not use this product Side Effects, Reactions & Medical Contraindications Contraindications Use is generally not recommended in: Known allergy or hypersensitivity to BPC157 or any component of the vial Pregnancy or breastfeeding (no adequate safety data) Active malignancy or history of cancer unless cleared by a specialist, due to theoretical concerns around angiogenesis and cellgrowth modulation Severe uncontrolled cardiovascular, renal, hepatic, or autoimmune disease without specialist supervision Competitive/regulated athletes subject to WADA or similar antidoping rules Common Side Effects and Adverse Reactions Local injectionsite reactions: redness, swelling, itching, bruising, pain Headache, dizziness or lightheadedness Nausea, stomach discomfort, diarrhea or constipation Fatigue, changes in energy or sleep disturbance Flushing or warmth sensations Because products are often unregulated, contamination or incorrect dosing may also contribute to side effects Reactions Requiring Medical Attention Patients should stop injections and seek urgent medical care (or emergency services, if severe) if they experience: Signs of a serious allergic reaction: widespread rash, hives, facial/tongue swelling, difficulty breathing Chest pain, severe shortness of breath or rapid heartbeat Severe or persistent abdominal pain, vomiting or bloody stools Sudden, unexplained swelling, rapid weight gain, or marked changes in blood pressure Any other new or worsening symptoms that feel serious or concerning Safety Note: Longterm data is limited

^ Partition and turnover of glutathione reductase from Saccharomyces cerevisiae: a proteomic approach (PDF)
Its rich foaming action ensures thorough cleansing while treating combination skin types gently
The researchers further suggest that GHRPs may also increase BMC/BMD
The 28-day rule, what shortens it, and how to tell when a vial has gone bad